Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,960) Arrow Down
Filter Results: (4,960) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,960)
    • People  (16)
    • News  (1,906)
    • Research  (2,472)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,882)

Show Results For

  • All HBS Web  (4,960)
    • People  (16)
    • News  (1,906)
    • Research  (2,472)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,882)
← Page 106 of 4,960 Results →
  • 29 Jan 2019
  • First Look

New Research and Ideas, January 29, 2019

generating consensus on the specifics of benefit-based taxation. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=55548 Harvard Business School Case 818-017 Pricing PatientPing In 2017, Jay Desai, the CEO of Boston-based View Details
Keywords: Dina Gerdeman
  • 19 Dec 2023
  • Research & Ideas

$15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy

comparison group. Top causes: education and health care Between 2020 and 2022, nonprofits in the youth, philanthropy, and housing sectors represented a larger share of grantees compared with the size of... View Details
Keywords: by Matthew Lee, Brian Trelstad, and Ethan Tran
  • October 2023
  • Article

What Does the Inflation Reduction Act Mean for Patients and Physicians?

By: Amitabh Chandra and Benedic Ippolito
The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed their effect on physicians and patients via their effect on payers. Reducing patients’ costs... View Details
Keywords: Government Legislation; Price; Health Care and Treatment
Citation
Find at Harvard
Purchase
Related
Chandra, Amitabh, and Benedic Ippolito. "What Does the Inflation Reduction Act Mean for Patients and Physicians?" NEJM Catalyst Innovations in Care Delivery 4, no. 10 (October 2023).
  • November 2008 (Revised July 2009)
  • Background Note

A Managerial Perspective on Clinical Trials

By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
  • March 2012
  • Article

Macroeconomic Policy and U.S. Competitiveness

By: Richard H.K. Vietor and Matthew Weinzierl
The United States is on a glide path to fiscal disaster, with experts projecting that the federal government will take in far less money than it spends-indefinitely. Our current fiscal policy is eroding competitiveness in several ways, and business conditions in the... View Details
Keywords: Macroeconomics; Government and Politics; Financial Crisis; Policy; Competition; Public Administration Industry; United States
Citation
Purchase
Related
Vietor, Richard H.K., and Matthew Weinzierl. "Macroeconomic Policy and U.S. Competitiveness." Harvard Business Review 90, no. 3 (March 2012).
  • 09 Oct 2017
  • News

Leemore Dafny on how to stay optimistic in the face of provider consolidation

  • 22 Aug 2005
  • Research & Ideas

Balancing the Future Against Today’s Needs

It is a classic leadership challenge of the early twenty-first century: How do you steer your business and motivate your people to pursue breakthrough growth while giving proper attention to executing the here and now with the utmost care... View Details
Keywords: by Paul Michelman
  • 07 Jan 2019
  • News

Decreases In Readmissions Credited To Medicare’s Program To Reduce Hospital Readmissions Have Been Overstated

  • January 2011 (Revised January 2012)
  • Case

The Case of the Unidentified Healthcare Companies2010

By: Richard Bohmer, Ethan Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected ratios for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
Keywords: Financial Reporting; Financial Statements; Health Care and Treatment; Health Industry
Citation
Educators
Purchase
Related
Bohmer, Richard, Ethan Bernstein, Margarita Krivitski, and Srinidhi Reddy. "The Case of the Unidentified Healthcare Companies2010." Harvard Business School Case 611-043, January 2011. (Revised January 2012.)
  • June 2004
  • Case

Medical Technology Industry and Japan (A), The

In a five-year effort, the Health Industry Manufacturers Association (HIMA) tried to influence government health policy in Japan. In 1993, HIMA mobilized in response to fears the Japanese government was planning to target the U.S. medical devices industry. The case... View Details
Keywords: Health Care and Treatment; Policy; Globalized Markets and Industries; Government and Politics; Medical Devices and Supplies Industry; Japan; United States
Citation
Educators
Purchase
Related
Watkins, Michael D., and Terri Zavada. "Medical Technology Industry and Japan (A), The." Harvard Business School Case 904-018, June 2004.
  • January 2023
  • Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
  • Career Coach

Betsy Edwards

Betsy (HGSE, '12) is a Corporate Relations Director in HBS Career & Professional Development with over ten years of coaching experience.  Her focus is on supporting students and alumni seeking an impact-oriented career primarily in the View Details
Keywords: Health Care; Health Care; Health Care; Health Care; Health Care; Health Care; Health Care; Health Care
  • 29 Jun 2020
  • News

After saving his own life with a repurposed drug, a professor reviews every drug being tried against Covid-19. Here's what he's found

  • 01 Apr 2013
  • News

Rx: Human Nature

  • 27 Feb 2017
  • News

Achieving Universal Coverage Without Turning to a Single Payer

  • 01 Apr 2020
  • News

The Varying International Responses to Covid-19, and the U.S. Stimulus Package

  • February 1996 (Revised April 1997)
  • Case

Partners HealthCare System, Inc. (A)

By: Gary P. Pisano and Maryam Golnaraghi
Focuses on the decision confronting senior administrators at the Brigham and Women's Hospital: whether to enter into an affiliation with the Massachusetts General Hospital. Requires students to analyze the complex institutional changes in the health environment and to... View Details
Keywords: Consolidation; Health Care and Treatment; Mergers and Acquisitions; Organizational Change and Adaptation; Change Management; Management Teams; Health Industry; Massachusetts
Citation
Educators
Purchase
Related
Pisano, Gary P., and Maryam Golnaraghi. "Partners HealthCare System, Inc. (A)." Harvard Business School Case 696-062, February 1996. (Revised April 1997.)
  • 17 Aug 2016
  • News

Have Obamacare? You might pay more with Aetna leaving the exchanges

  • 04 Nov 2015
  • News

M.B.A.s Get Lessons in Income Inequality

  • Article

Internal Deadlines, Drug Approvals, and Safety Problems

By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details
Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Health Industry; Health Industry; Health Industry
Citation
SSRN
Find at Harvard
Related
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.
  • ←
  • 106
  • 107
  • …
  • 247
  • 248
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.